Associations between components of metabolic syndrome and cognitive impairment in patients with schizophrenia
OBJECTIVE: To study the relationship between the individual components of the metabolic syndrome and cognitive dysfunction in patients with schizophrenia.
MATERIAL AND METHODS: A total of 133 patients with schizophrenia were examined. To assess cognitive functioning, the Brief Assessment of Cognition in Schizophrenia (BACS) was used. The components of the metabolic syndrome were determined in accordance with the criteria of the International Diabetes Federation.
RESULTS: Hyperglycemia in patients with schizophrenia led to a decrease in cognitive functioning in two domains: verbal fluency (β=-10.67; p=0.019) and attention stability (β=-9.519; p=0.043). Abdominal obesity was associated with lower indicators of executive functions (β=-8.856; p=0.026).
CONCLUSION: It is assumed that drug treatment of some components of the metabolic syndrome may affect cognitive functions in patients with schizophrenia.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:124 |
|---|---|
| Enthalten in: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 124(2024), 3 vom: 31., Seite 82-87 |
| Sprache: |
Russisch |
|---|
| Weiterer Titel: |
Svyazi mezhdu komponentami metabolicheskogo sindroma i kognitivnymi narusheniyami u bol'nykh shizofreniei |
|---|
| Beteiligte Personen: |
Kornetova, E G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Abdominal obesity |
|---|
| Anmerkungen: |
Date Completed 27.03.2024 Date Revised 27.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.17116/jnevro202412403182 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370194284 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370194284 | ||
| 003 | DE-627 | ||
| 005 | 20240328000600.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2024 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.17116/jnevro202412403182 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1351.xml |
| 035 | |a (DE-627)NLM370194284 | ||
| 035 | |a (NLM)38529867 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Kornetova, E G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Associations between components of metabolic syndrome and cognitive impairment in patients with schizophrenia |
| 246 | 3 | 3 | |a Svyazi mezhdu komponentami metabolicheskogo sindroma i kognitivnymi narusheniyami u bol'nykh shizofreniei |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.03.2024 | ||
| 500 | |a Date Revised 27.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVE: To study the relationship between the individual components of the metabolic syndrome and cognitive dysfunction in patients with schizophrenia | ||
| 520 | |a MATERIAL AND METHODS: A total of 133 patients with schizophrenia were examined. To assess cognitive functioning, the Brief Assessment of Cognition in Schizophrenia (BACS) was used. The components of the metabolic syndrome were determined in accordance with the criteria of the International Diabetes Federation | ||
| 520 | |a RESULTS: Hyperglycemia in patients with schizophrenia led to a decrease in cognitive functioning in two domains: verbal fluency (β=-10.67; p=0.019) and attention stability (β=-9.519; p=0.043). Abdominal obesity was associated with lower indicators of executive functions (β=-8.856; p=0.026) | ||
| 520 | |a CONCLUSION: It is assumed that drug treatment of some components of the metabolic syndrome may affect cognitive functions in patients with schizophrenia | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a abdominal obesity | |
| 650 | 4 | |a cognitive impairment | |
| 650 | 4 | |a dyslipidemia | |
| 650 | 4 | |a hyperglycemia | |
| 650 | 4 | |a hypertension | |
| 650 | 4 | |a metabolic syndrome | |
| 650 | 4 | |a schizophrenia | |
| 700 | 1 | |a Galkin, S A |e verfasserin |4 aut | |
| 700 | 1 | |a Mednova, I A |e verfasserin |4 aut | |
| 700 | 1 | |a Tsiguntsev, V V |e verfasserin |4 aut | |
| 700 | 1 | |a Boiko, A S |e verfasserin |4 aut | |
| 700 | 1 | |a Kornetov, A N |e verfasserin |4 aut | |
| 700 | 1 | |a Ivanova, S A |e verfasserin |4 aut | |
| 700 | 1 | |a Bokhan, N A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova |d 1997 |g 124(2024), 3 vom: 31., Seite 82-87 |w (DE-627)NLM074605267 |x 1997-7298 |7 nnns |
| 773 | 1 | 8 | |g volume:124 |g year:2024 |g number:3 |g day:31 |g pages:82-87 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.17116/jnevro202412403182 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 124 |j 2024 |e 3 |b 31 |h 82-87 | ||